Who is sponsoring NCT05949151?

NCT05949151 is sponsored by Asmaa Nabil Elboraey.

What drugs are being tested in NCT05949151?

Interventions in NCT05949151: dental implants (K1 line conical connection double thread, OXY, Italy), Occlusense (Bausch GmbH & Co. KG), electromyography (EMG) (Nemus II)"., oral health-related quality of life (OHRQoL).

Is NCT05949151 still recruiting?

NCT05949151 is currently completed. Last updated 17 July 2023.

Last reviewed 2023-07-17 · How we verify

NCT05949151

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Occlusal Forces and Muscle Activity in Fixed Versus Removable Mandibular Implant Supported Overdenture

Completed NA Last updated 17 July 2023

What this trial tests

NA trial testing dental implants (K1 line conical connection double thread, OXY, Italy) in Occlusion in 22 participants. Completed in 1 May 2023.

Timeline

1 January 2023

Primary endpoint
1 March 2023

1 May 2023

Quick facts

Lead sponsor	Asmaa Nabil Elboraey
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	22
Start date	1 January 2023
Primary completion	1 March 2023
Estimated completion	1 May 2023
Sites	1 location across Egypt

Drugs / interventions tested

dental implants (K1 line conical connection double thread, OXY, Italy)
Occlusense (Bausch GmbH & Co. KG)
electromyography (EMG) (Nemus II)".
oral health-related quality of life (OHRQoL)

Conditions studied

Occlusion — all drugs for Occlusion →

Sponsor

Asmaa Nabil Elboraey

Who can join

Adults 55 to 60, male only, with Occlusion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

22 Patients having lower completely edentulous mandible aged 55-60 years were selected from the outpatient dental clinic of the Medical Excellence Centre of the National Research (NRC) Cairo, Egypt. Six dental implants were inserted in the mandible of each patient. The patients were randomly categorized into two groups according to the final restoration.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Occlusal equilibration and muscle activity in fixed versus removable mandibular implant supported overdenture.
Elboraey AN, Dehis WM, Eissa SM, El-Hotieby MM, et al · · 2024 · cited 2× · PMID 38378935 · DOI 10.1007/s00784-024-05558-w

Verify or expand the search:

Other recruiting trials for Occlusion

Currently open trials in the same condition.

NCT06365528 — Tunneled Peripherally Inserted Central Catheter (PICC) in Adult Patients and Associated Outcomes · NA · recruiting
NCT06052501 — 3D Evaluation of the Lip Support in a Full-arch Implant-supported Rehabilitations · recruiting

Other Asmaa Nabil Elboraey trials

Trials by the same sponsor.

NCT05955989 — Relining Assessment of Digital and Conventional Fabricated Complete Denture Base · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05949151 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Asmaa Nabil Elboraey
Last refreshed: 17 July 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05949151.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing